The transcription factor p53 is the most frequently inactivated tumour suppressor in cancer. Approaches to restore its wild-type function are challenging and have not led to approved drugs. An ...
For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib ...
SHANNON, CLARE, IRELAND, April 6, 2026 /EINPresswire.com/ — Researchers have identified a novel therapeutic approach for colorectal cancer by exploiting a specific ...
XtalPi (2228.HK), a leading AI- and robotics-powered innovation platform, today announced dual breakthroughs in its strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results